English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
National Center for Policy Analysis
+
Community
Vimbai Chikomo
| Dec 27, 2016
Health economist expresses concern over accuracy claim of 'opioid risk' test
+
Community
Vimbai Chikomo
| Dec 6, 2016
Health care expert names coordinated care key to reduced spending
+
Regulatory
Kerry Goff
| Jul 5, 2016
Senators call for patient cost-sharing relief
+
Regulatory
Kerry Goff
| Jun 21, 2016
Arizona's 65 percent Obamacare price hike request was inevitable, NCPA analyst says
+
Regulatory
Vimbai Chikomo
| Apr 25, 2016
Health care expert says Obamacare may be at a tipping point and going 'downhill very fast'
+
Regulatory
Kerry Goff
| Apr 4, 2016
NCPA fellow does not see clear solution for shortage of HSA-eligible consumers
+
Regulatory
Kerry Goff
| Mar 28, 2016
NCPA fellow backs Republican claims surrounding Obamacare lawbreaking
+
Regulatory
Kerry Goff
| Mar 17, 2016
Auditors uncover possible Obamacare fraud; NCPA fellow responds
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes